Immunogenicity and safety of a SARS-CoV-2 inactivated vaccine (CoronaVac) co-administered with an inactivated quadrivalent influenza vaccine: A randomized, open-label, controlled study in healthy adults aged 18 to 59 years in China
Wang Shenyu, Xiaoqian Duan, Bo Chen, Deng Xuan, Zeng Wang, Zhang Hangjie, Qianhui Zheng, Zhenzhen Liang, Yan Chuanfu, Yang Juan, Gang Zeng, Huakun Lv
Topics & Concepts
SeroconversionMedicineImmunogenicityAdverse effectConfidence intervalRandomized controlled trialInfluenza vaccineInternal medicineSubgroup analysisInactivated vaccineAntibodyInfluenza A virusVirologyImmunologyVaccinationVirusSARS-CoV-2 and COVID-19 ResearchInfluenza Virus Research StudiesRespiratory viral infections research